Carlos Ruiz

Carlos Ruiz and performance-enhancing drugs

24 Comments

There are a lot of differing opinions out there, educated and otherwise, on just how much performance-enhancing drugs actually enhance performance. On the one side, there’s suspected users like Barry Bonds and Roger Clemens pulling off incredible feats at advanced ages. On the other, there’s the long list of proven cheaters littered with names of journeymen long forgotten.

Now, though, that long list has suddenly gotten interesting at the end. The last three veteran major leaguers caught cheating were all exceeding expectations in a pretty big way:

– Melky Cabrera, the 2012 All-Star Game MVP, was leading the NL with a .346 average through 113 games when he was suspended. His OPS went from .671 in 2010 to .809 in 2011 to .906 last season.

– Bartolo Colon had a 3.43 ERA in 24 starts for Oakland prior to his suspension. Two years after his career was presumed over due to shoulder problems, he was on his way to his best season since 2005. Had he maintained the 3.43 ERA, it would have been his second-lowest mark in 15 big-league seasons.

– Carlos Ruiz established new career highs in average (.325), homers (16) and RBI (68) as a 33-year-old last season. The homer total was two more than he had the previous two seasons combined. His .540 slugging percentage was almost 150 points higher than his career mark of .393.

Of course, Ruiz, unlike the other two, wasn’t caught with testosterone. And because he was using an amphetamine, not a steroid, he’s getting just a 25-game suspension (Cabrera and Colon received 50 games apiece).

Whether the Adderall deserves any credit for Ruiz’s performance spike is a matter I’ll let others debate. But it’s more ammunition for those who believe that cheaters get an incredible advantage over those who get their results naturally.

Phil Bickford suspended 50 games for drug of abuse

SAN DIEGO, CA - JULY 10:  Phil Bickford of the U.S. Team pitches during the SiriusXM All-Star Futures Game at PETCO Park on July 10, 2016 in San Diego, California.  (Photo by Sean M. Haffey/Getty Images)
Getty Images
1 Comment

Brewers’ right-hander Phil Bickford received a 50-game suspension after testing positive for a drug of abuse, per the Los Angeles Times’ Bill Shaikin. This is the second time Bickford has been suspended for recreational drug use, as he was previously penalized in 2015 after testing positive for marijuana prior to the amateur draft.

Bickford was selected by the Giants in the first round of the 2015 draft and was later dealt to the Brewers for lefty reliever Will Smith at the 2016 trade deadline. He finished his 2016 campaign in High-A Brevard County, pitching to a 3.67 ERA, 10.0 K/9 rate and 5.0 BB/9 over 27 innings.

Two other suspensions were handed down on Friday, one to Toronto minor league right-hander Pedro Loficial for a positive test for metabolites of Stanozolol and one to Miami minor league outfielder Casey Soltis for a second positive test for drugs of abuse. Loficial will serve a 72-game suspension, while Soltis will serve 50 games. All three suspensions are due to start at the beginning of the 2017 season for each respective minor league team.

Brewers’ GM David Stearns issued a statement after the Commissioner’s Office announced Bickford’s suspension (via Vince Lara-Cinisomo of Baseball America):

We are very disappointed to learn of Phil’s suspension, but we fully support the Minor League Baseball Drug Prevention and Testing Program and its enforcement by the Commissioner’s Office. Phil understands he made a mistake, and we fully anticipate that he will learn from this experience.

Diamondbacks sign Fernando Rodney to a one-year, $2.75 million deal

PITTSBURGH, PA - AUGUST 21:  Fernando Rodney #56 of the Miami Marlins pitches during the game against the Pittsburgh Pirates on August 21, 2016 at PNC Park in Pittsburgh, Pennsylvania.  (Photo by Joe Sargent/Getty Images) *** Local Caption ***
Getty Images
Leave a comment

Confirming a report from Tuesday, the Diamondbacks officially signed right-hander Fernando Rodney to a one-year, $2.75 million contract on Friday. The 39-year-old stands to receive up to $4 million in incentives, per Jack MacGruder of FanRag Sports, with $250,000 kicking in when the veteran reaches 40, 50 and 60 appearances and $500,000 if he reaches 70.

Rodney came three games shy of the 70-appearance mark in 2016 during back-to-back stints with the Padres and Marlins. He put up a cumulative 3.44 ERA on the year, which effectively disguised the extreme split during his performances in San Diego and Miami. The Diamondbacks aren’t anywhere close to contending in 2017, but Rodney should stabilize the back end of their bullpen while providing Arizona GM Mike Hazen with a potential trade chip during next year’s deadline.

Hazen issued a statement following the signing:

With Fernando, we’re getting an established Major League closer and a veteran presence in the bullpen. It is helpful to have someone with his experience on the back end to slow the game down and get the final three outs.